“Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors” (2022) Journal of Pharmaceutical Negative Results, 13(3), pp. 559–571. doi:10.47750/pnr.2022.13.03.085.